Tharimmune to participate in two upcoming investor conferences in may

Bridgewater, nj / accesswire / april 30, 2024 / tharimmune, inc. (nasdaq:thar) ("tharimmune" or the "company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation & immunology announced that management will be participating in two investor conferences in may. randy milby, chief executive officer, will be presenting at the planet microcap showcase: vegas 2024 being held at the paris hotel & casino in las vegas, nevada, and will hold 1x1 meetings with investors.
THAR Ratings Summary
THAR Quant Ranking